Role of intermittent fasting in prevention against development of non-alcoholic steatohepatitis (NASH) and hepatocellular carcinoma (HCC)

Ähnliche Einträge

• Role of intermittent fasting in prevention against development of non-alcoholic steatohepatitis (NASH) and hepatocellular carcinoma (HCC)
  von: Ali, Sheikh Adnan
  Veröffentlicht: (2023)
• A 5:2 intermittent fasting regimen ameliorates NASH and fibrosis and blunts HCC development via hepatic PPARα and PCK1
  von: Gallage, Suchira, et al.
  Veröffentlicht: (2024)
• Exploring the effects of different bile acids receptor agonists in Non-Alcoholic Steatohepatitis (NASH) and NASH-related hepatocarcinogenesis
  von: Focaccia, Enrico, et al.
  Veröffentlicht: (2023)
• Molecular characterisation of hepatocellular carcinoma in patients with non-alcoholic steatohepatitis
  von: Pinyol i Agelet, Roser, et al.
  Veröffentlicht: (2021)
• Detection of carcinogenic etheno-DNA adducts in children and adolescents with non-alcoholic steatohepatitis (NASH)
  von: Teufel-Schäfer, Ulrike, et al.
  Veröffentlicht: (2015)